Clinically proven to help
prevent motion sickness
One Transderm Scōp® patch
lasts up to 3 days
In clinical trials 5 out of 6 patients did not report drowsiness with the Transderm Scōp® patch

Important Safety Information

A prescription is needed. Not for children under 18 years old or people who have or have had glaucoma (increased pressure in the eyeball), have difficulty urinating, or an allergy to the active ingredient, scopolamine or other belladonna alkaloids. Most common side effects are dry mouth, drowsiness and blurred vision. When using this product, do not use alcohol, drive, operate dangerous machinery, or do things requiring alertness. If you are elderly, your physician should exercise care in prescribing the Transderm Scōp® patch.

Download full Prescribing information here


© 2008 Novartis Consumer Health, Inc. All Rights Reserved. Your use of this website is subject to the terms of our Legal Statement and Privacy Policy. The product information contained in this site is intended for residents of the United States only. For more information on Novartis and other Novartis products, see Novartis.com. Site Map